Inhibitory effect of epirubicin-loaded lipid microbubbles with conjugated anti-ABCG2 antibody combined with therapeutic ultrasound on multiple myeloma cancer stem cells

References

• Borrello I. Can we change the disease biology of multiple myeloma? Leuk Res 2012;36:S3–S12
   PubMed Web of Science ®Google Scholar
• Bladé J, Cibeira MT, Fernández de Larrea C, et al. Multiple myeloma. Ann Oncol 2010;21: vii313–19
   PubMed Web of Science ®Google Scholar
• Saini N, Mahindra A. Therapeutic strategies for the treatment of multiple myeloma. Discov Med 2013;15:251–8
   PubMed Web of Science ®Google Scholar
• Chou T. Multiple myeloma: recent progress in diagnosis and treatment. J Clin Exp Hematopathol 2012;52:149–59
   PubMedGoogle Scholar
• Paíno T, Ocio EM, Paiva B, et al. CD20 positive cells are undetectable in the majority of multiple myeloma cell lines and are not associated with a cancer stem cell phenotype. Haematologica 2012;97:1110–14
   PubMed Web of Science ®Google Scholar
• Agarwal JR, Matsui W. Multiple myeloma: a paradigm for translation of the cancer stem cell hypothesis. Anti-Cancer Agents Med Chem 2010;10:116–20
   PubMed Web of Science ®Google Scholar
• Ghosh N, Matsui W. Cancer stem cells in multiple myeloma. Cancer Lett 2009;277:1–7
   PubMed Web of Science ®Google Scholar
• Fratino L, Rupolo M, Mazzuccato M, et al. Autologous stem cell transplantation and multiple myeloma cancer stem cells. Anticancer Agents Med Chem 2013;13:1419–29
   PubMed Web of Science ®Google Scholar
• Matsui W, Huff CA, Wang Q, et al. Characterization of clonogenic multiple myeloma cells. Blood 2004;103:2332–6
   PubMed Web of Science ®Google Scholar
• Hajek R, Okubote SA, Svachova H. Myeloma stem cell concepts, heterogeneity and plasticity of multiple myeloma. Br J Haematol 2013;163:551–64
   PubMed Web of Science ®Google Scholar
• Villa R, Cerroni B, Viganò L, et al. Targeted doxorubicin delivery by chitosan-galactosylated modified polymer microbubbles to hepatocarcinoma cells. Colloids Surf B Biointerfaces 2013;110:434–42
   PubMed Web of Science ®Google Scholar
• Geers B, De Wever O, Demeester J, et al. Targeted liposome-loaded microbubbles for cell-specific ultrasound-triggered drug delivery. Small 2013;9:4027–35
   PubMed Web of Science ®Google Scholar
• Ren ST, Liao YR, Kang XN, et al. The antitumor effect of a new docetaxel-loaded microbubble combined with low-frequency ultrasound in vitro: preparation and parameter analysis. Pharm Res 2013;30:1574–85
   PubMed Web of Science ®Google Scholar
• Sorace AG, Warram JM, Umphrey H, et al. Microbubble-mediated ultrasonic techniques for improved chemotherapeutic delivery in cancer. J Drug Target 2012;20:43–54
   PubMed Web of Science ®Google Scholar
• Azmin M, Harfield C, Ahmad Z, et al. How do microbubbles and ultrasound interact? Basic physical, dynamic and engineering principles. Curr Pharm Des 2012;18:2118–34
   PubMed Web of Science ®Google Scholar
• Wang Y, Bai WK, Shen E, et al. Sonoporation by low-frequency and low-power ultrasound enhances chemotherapeutic efficacy in prostate cancer cells in vitro. Oncol Lett 2013;6:495–8
   PubMed Web of Science ®Google Scholar
• Liu H, Chang S, Sun J, et al. Ultrasound-mediated destruction of LHRHa-targeted and paclitaxel-loaded lipid microbubbles induces proliferation inhibition and apoptosis in ovarian cancer cells. Mol Pharm 2014;11:40–8
   PubMed Web of Science ®Google Scholar
• Abe M, Harada T, Matsumoto T. Concise review: defining and targeting myeloma stem cell-like cells. Stem Cells 2014;32:1067–73
   PubMed Web of Science ®Google Scholar
• Lu CT, Zhao YZ, Wu Y, et al. Experiment on enhancing antitumor effect of intravenousepirubicin hydrochloride by acoustic cavitation in situ combined with phospholipid-based microbubbles. Cancer Chemother Pharmacol 2011;68:343–8
   PubMed Web of Science ®Google Scholar
• Tinkov S, Coester C, Serba S, et al. New doxorubicin-loaded phospholipid microbubbles for targeted tumor therapy: in vivo characterization. J Control Release 2010;148:368–72
   PubMed Web of Science ®Google Scholar
• Tinkov S, Winter G, Coester C, Bekeredjian R. New doxorubicin-loaded phospholipid microbubbles for targeted tumor therapy: Part I – formulation development and in vitro characterization. J Control Release 2010;143:143–50
   PubMed Web of Science ®Google Scholar
• Yang F, Zhang M, He W, et al. Controlled release of Fe3O4 nanoparticles in encapsulated microbubbles to tumor cells via sonoporation and associated cellular bioeffects. Small 2011;7:902–10
   PubMed Web of Science ®Google Scholar
• Wang C, Yang F, Xu Z, et al. Intravenous release of NO from lipidic microbubbles accelerates deep vein thrombosis resolution in a rat model. Thromb Res 2013;131:e31–8
   PubMed Web of Science ®Google Scholar
• Yang F, Gu N, Chen D, et al. Experimental study on cell self-sealing during sonoporation. J Control Release 2008;131:205–10
   PubMed Web of Science ®Google Scholar
• Wang L, Li L, Guo Y, et al. Construction and in vitro/in vivo targeting of PSMA-targeted nanoscale microbubbles in prostate cancer. Prostate 2013;73:1147–58
   PubMed Web of Science ®Google Scholar
• Niu C, Wang Z, Lu G, et al. Doxorubicin loaded superparamagnetic PLGA-iron oxide multifunctional microbubbles for dual-mode US/MR imaging and therapy of metastasis in lymph nodes. Biomaterials 2013;34:2307–17
   PubMed Web of Science ®Google Scholar
• Yang CP, Xiong F, Wang J, et al. Anti-ABCG2 monoclonal antibody in combination with paclitaxel nanoparticles against cancer stem-like cell activity in multiple myeloma. Nanomedicine 2014;9:45–60
   PubMed Web of Science ®Google Scholar
• Yang CP, Wang J, Chen D, et al. Paclitaxel-Fe3O4 nanoparticles inhibits the growth of CD138−CD34− tumor stem-like cells in multiple myeloma bearing mice. Int J Nanomed 2013;8:1439–49
   PubMed Web of Science ®Google Scholar
• Dou J, Pan M, Wen P, et al. Isolation and identification of cancer stem like cells from murine melanoma cell lines. Cell Mol Immunol 2007;4:467–72
   PubMed Web of Science ®Google Scholar
• Chen DY, Wang J, Zhang Y, et al. Effect of downregulated transcriptional repressor ZEB1 on the epithelial-mesenchymal transition of ovarian cancer cells. Int J Gynecol Cancer 2013;23:1357–66
   PubMed Web of Science ®Google Scholar
• Lo YL, Ho CT, Tsai FL. Inhibit multidrug resistance and induce apoptosis by using glycocholic acid and epirubicin. Eur J Pharm Sci 2008;35:52–67
   PubMed Web of Science ®Google Scholar
• Lo Y-L. A potential daidzein derivative enhances cytotoxicity of epirubicin on human colon adenocarcinoma Caco-2 cells. Int J Mol Sci 2013;14:158–76
   Web of Science ®Google Scholar
• Chen JS, Wang J, Zhang Y, et al. Analysis of ovarian cancer stem cell behavior and drug resistance in a three dimensional cell culture. J Biosci Bioeng 2014;118:214–22
   PubMed Web of Science ®Google Scholar
• Zhang Y, Hu H, Song L, et al. Epirubicin-mediated expression of miR-302b is involved in osteosarcoma apoptosis and cell cycle regulation. Toxicol Lett 2013;222:1–9
   PubMed Web of Science ®Google Scholar
• Sun WL, Chen J, Wang YP, et al. Autophagy protects breast cancer cells from epirubicin-induced apoptosis and facilitates epirubicin-resistance development. Autophagy 2011;7:1035–44
   PubMed Web of Science ®Google Scholar
• Villa CH, Dao T, Ahearn I, et al. Single walled carbon nanotubes deliver peptideantigen into dendritic cells and enhance IgG responses to tumor-associated antigens. ACS Nano 2011;5:5300–11
   PubMed Web of Science ®Google Scholar
• Cirstea D, Hideshima T, Rodig S, et al. Dual inhibition of akt/mammaliantarget of rapamycin pathway by nanoparticle albumin-bound–rapamycin and perifosine induces antitumor activity in multiple myeloma. Mol Cancer Ther 2010;9:963–75
   PubMed Web of Science ®Google Scholar
• Hu W, Wang J, Dou J, et al. Augmenting therapy of ovarian cancer efficacy by secreting IL-21 human umbilical cordblood stem cells in nude mice. Cell Transplant 2011;20:669–80
   PubMed Web of Science ®Google Scholar
• Yang CP, He XF, Chen JS, et al. Fe3O4 nanoparticle loaded paclitaxel induce multiple myeloma apoptosis by cell cycle arrest and increase cleavage of caspases in vitro. J Nanopart Res 2013;15:1840
   Web of Science ®Google Scholar
• Twomey C, McCarthy JV. Pathways of apoptosis and importance in development. J Cell Mol Med 2005;9:345–59
   PubMed Web of Science ®Google Scholar
• Li P, Nijhawan D, Budihardjo I, et al. Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell 1997;91:479–89
   PubMed Web of Science ®Google Scholar